SEC Form 4 · accession 0001179110-15-015628
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Bjerkholt
Officer — EVP, CFO & Corp. Secretary
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 8:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.03 | Nov 30, 2015 | A | 270,000 | A | — | Nov 29, 2025 | Common Stock | 270,000 | 270,000 | D |
Explanation of responses
- F1Forty Per Cent (40%) of the options shall vest one year from November 30, 2015 and the balance of the shares shall vest monthly thereafter in eighteen (18) equal installments.